By Toni Clarke (Reuters) – The U.S. Food and Drug Administration has approved NPS Pharmaceuticals Inc’s drug Natpara to treat a rare hormone disorder, validating a bet by Shire Plc, which recently agreed to acquire NPS for $5.2 billion. Natpara is designed to …
Source:FDA approves NPS drug, in move validating Shire takeover deal
Saturday, January 24, 2015
FDA approves NPS drug, in move validating Shire takeover deal
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment